Esra A. Akbay - Concepedia

Author

Esra A. Akbay

The University of Texas Southwestern Medical Center ORCID

Also Known As

Akbay, Esra A., Chen, Ting, E A Akbay, E. Akbay, Esra A Akbay, Esra A. Akbay, Esra Akbay, Esra A. Akbay, Kwiatkowski, David J., Mikse, Oliver R.

170

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital

About

Esra A. Akbay is an author at The University of Texas Southwestern Medical Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	20	2.7K
2	Engineering	2	2	93
3	Public Health	2	2	358
4	Health Sciences	1	1	14
5	Natural Sciences	1	1	61

Esra A. Akbay

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints Shohei Koyama, Esra A. Akbay, Yvonne Y. Li, Nature Communications	2016	1.5K
Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors Esra A. Akbay, Shohei Koyama, Julián Carretero, Cancer Discovery	2013	1.2K
STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment Shohei Koyama, Esra A. Akbay, Yvonne Y. Li, Cancer Research	2016	605
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer Supriya K. Saha, Christine A. Parachoniak, Krishna S. Ghanta, Nature Tumor BiologyPromote Biliary CancerHepatologyBiliary CancerLiver Physiology	2014	455
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor Camilla L. Christensen, Nicholas Kwiatkowski, Brian J. Abraham, Cancer Cell MedicineImmune Checkpoint InhibitorCancer BiologyAnti-cancer AgentCovalent Cdk7 Inhibitor	2014	449
Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression Chunxiao Xu, Christine M. Fillmore, Shohei Koyama, Cancer Cell Tumor BiologyPten LeadsMedicinePathologyBronchial Neoplasm	2014	378
Somatic LKB1 Mutations Promote Cervical Cancer Progression Shana N. Wingo, Teresa D. Gallardo, Esra A. Akbay, PLoS ONE Cervical Cancer ScreeningCervical Cancer ProgressionPrecancerous LesionsCervical CancerHuman Papillomavirus Vaccines	2009	266
Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients Akio Osa, Takeshi Uenami, Shohei Koyama, JCI Insight	2018	225
Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non–Small Cell Lung Cancer Takeshi Shimamura, Zhao Chen, Margaret Soucheray, Clinical Cancer Research	2013	200
Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade Esra A. Akbay, Shohei Koyama, Yan Liu, Journal of Thoracic Oncology	2017	189

Page 1